Jump to main content
Jump to site search

Issue 15, 2014
Previous Article Next Article

Evaluating the sensitivity of hybridization-based epigenotyping using a methyl binding domain protein

Author affiliations

Abstract

Hypermethylation of CpG islands in gene promoter regions has been shown to be a predictive biomarker for certain diseases. Most current methods for methylation profiling are not well-suited for clinical analysis. Here, we report the development of an inexpensive device and an epigenotyping assay with a format conducive to multiplexed analysis.

Graphical abstract: Evaluating the sensitivity of hybridization-based epigenotyping using a methyl binding domain protein

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 14 Apr 2014, accepted on 28 Apr 2014 and first published on 28 Apr 2014


Article type: Communication
DOI: 10.1039/C4AN00667D
Citation: Analyst, 2014,139, 3695-3701
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Evaluating the sensitivity of hybridization-based epigenotyping using a methyl binding domain protein

    B. W. Heimer, T. A. Shatova, J. K. Lee, K. Kaastrup and H. D. Sikes, Analyst, 2014, 139, 3695
    DOI: 10.1039/C4AN00667D

Search articles by author